Skip to main content
logo
AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
7.49
-0.46 (-5.79%)
At close: Oct 30, 2026, 4:00 PM EDT
7.40
-0.09 (-1.20%)
After-hours: Oct 30, 2026, 7:30 PM EDT

AgomAb Therapeutics NV Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Market Capitalization
369-----
Market Cap Growth
------
Enterprise Value
82-----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Debt / Equity Ratio
0.000.010.010.010.00-
Net Debt / Equity Ratio
-0.94-0.88-0.90-0.80-1.02-1.11
Net Debt / EBITDA Ratio
3.831.963.543.892.99-
Net Debt / FCF Ratio
4.422.233.584.913.57-
Quick Ratio
12.556.4919.0212.802.39-
Current Ratio
12.886.5219.0512.812.39-
Return on Equity (ROE)
--39.22%-27.26%-10.46%--90.33%
Return on Assets (ROA)
--20.58%-15.90%-14.32%--49.38%
Return on Capital Employed (ROCE)
-24.30%-43.90%-24.30%-19.40%-31.80%-41.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Buyback Yield / Dilution
-3716.54%--0.00%--
SEC Filings: 10-K · 10-Q